Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Firategrast in relapsing multiple sclerosis
NCT00097331Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of firategrast in multiple sclerosis (MS), sponsored by GSK. Started Sep 2004; status: completed.
02
Drugs
firategrast
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00097331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097331.